Search

Kurt Fernstrom

Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )

Most Active Art Unit
3711
Art Unit(s)
3714, 3712, 3715, 3711
Total Applications
2669
Issued Applications
1756
Pending Applications
157
Abandoned Applications
755

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16969285 [patent_doc_number] => 11065231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-20 [patent_title] => Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides [patent_app_type] => utility [patent_app_number] => 16/194094 [patent_app_country] => US [patent_app_date] => 2018-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 99906 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 694 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16194094 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/194094
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides Nov 15, 2018 Issued
Array ( [id] => 16336542 [patent_doc_number] => 10787486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-29 [patent_title] => Template-fixed peptidomimetics [patent_app_type] => utility [patent_app_number] => 16/190459 [patent_app_country] => US [patent_app_date] => 2018-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6295 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16190459 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/190459
Template-fixed peptidomimetics Nov 13, 2018 Issued
Array ( [id] => 16539391 [patent_doc_number] => 20200405804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => COMPOSITIONS AND METHOD FOR THE TREATMENT OF X-LINKED CENTRONUCLEAR MYOPATHY [patent_app_type] => utility [patent_app_number] => 16/762953 [patent_app_country] => US [patent_app_date] => 2018-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762953 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/762953
Compositions and method for the treatment of x-linked centronuclear myopathy Nov 11, 2018 Issued
Array ( [id] => 14040789 [patent_doc_number] => 20190076501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => OXYTOCIN IMPROVES TREATMENT OF OBSTRUCTIVE SLEEP APNEA [patent_app_type] => utility [patent_app_number] => 16/184091 [patent_app_country] => US [patent_app_date] => 2018-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16184091 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/184091
Oxytocin improves treatment of obstructive sleep apnea Nov 7, 2018 Issued
Array ( [id] => 17664195 [patent_doc_number] => 11357871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Challenge test for diagnosing subtypes of ASD [patent_app_type] => utility [patent_app_number] => 16/182544 [patent_app_country] => US [patent_app_date] => 2018-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9367 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16182544 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/182544
Challenge test for diagnosing subtypes of ASD Nov 5, 2018 Issued
Array ( [id] => 16908100 [patent_doc_number] => 11040117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-22 [patent_title] => Treatment of a subtype of ASD [patent_app_type] => utility [patent_app_number] => 16/182546 [patent_app_country] => US [patent_app_date] => 2018-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6832 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16182546 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/182546
Treatment of a subtype of ASD Nov 5, 2018 Issued
Array ( [id] => 17680080 [patent_doc_number] => 11364311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-21 [patent_title] => Method of identifying ASD phenotype 1 patients [patent_app_type] => utility [patent_app_number] => 16/182539 [patent_app_country] => US [patent_app_date] => 2018-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9022 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16182539 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/182539
Method of identifying ASD phenotype 1 patients Nov 5, 2018 Issued
Array ( [id] => 15466181 [patent_doc_number] => 10548944 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-02-04 [patent_title] => Antimicrobial peptides and methods of using the same [patent_app_type] => utility [patent_app_number] => 16/165727 [patent_app_country] => US [patent_app_date] => 2018-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 20760 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165727 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/165727
Antimicrobial peptides and methods of using the same Oct 18, 2018 Issued
Array ( [id] => 16948123 [patent_doc_number] => 20210206814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => METHODS AND MATERIALS FOR GENE EDITING [patent_app_type] => utility [patent_app_number] => 16/754898 [patent_app_country] => US [patent_app_date] => 2018-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10658 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754898 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/754898
METHODS AND MATERIALS FOR GENE EDITING Oct 11, 2018 Abandoned
Array ( [id] => 16310878 [patent_doc_number] => 20200289616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => HUMAN CANCER CELL METASTASIS INHIBITORY AGENT AND HUMAN CANCER CELL DETERMINATION AGENT [patent_app_type] => utility [patent_app_number] => 16/765757 [patent_app_country] => US [patent_app_date] => 2018-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765757 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/765757
Human cancer cell metastasis inhibitory agent and human cancer cell determination agent Sep 25, 2018 Issued
Array ( [id] => 18620421 [patent_doc_number] => 11753449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => Immunoglobulin binding protein, and affinity support using same [patent_app_type] => utility [patent_app_number] => 16/649879 [patent_app_country] => US [patent_app_date] => 2018-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14325 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649879 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/649879
Immunoglobulin binding protein, and affinity support using same Sep 24, 2018 Issued
Array ( [id] => 14132329 [patent_doc_number] => 20190100554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-04 [patent_title] => METHOD FOR SYNTHESIZING ETELCALCETIDE OR SALTS THEREOF [patent_app_type] => utility [patent_app_number] => 16/137967 [patent_app_country] => US [patent_app_date] => 2018-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4023 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137967 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/137967
Method for synthesizing etelcalcetide or salts thereof Sep 20, 2018 Issued
Array ( [id] => 16437081 [patent_doc_number] => 20200354407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => PEPTIDE INHIBITORS OF INSULIN-DEGRADING ENZYME [patent_app_type] => utility [patent_app_number] => 16/641995 [patent_app_country] => US [patent_app_date] => 2018-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641995 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/641995
Peptide inhibitors of insulin-degrading enzyme Sep 10, 2018 Issued
Array ( [id] => 16776630 [patent_doc_number] => 20210113707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => AMANITIN ANTIBODY CONJUGATE [patent_app_type] => utility [patent_app_number] => 16/970597 [patent_app_country] => US [patent_app_date] => 2018-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970597 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/970597
AMANITIN ANTIBODY CONJUGATE Sep 7, 2018 Abandoned
Array ( [id] => 17281691 [patent_doc_number] => 11198711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-14 [patent_title] => Pesticidal fusion protein improvements [patent_app_type] => utility [patent_app_number] => 16/123860 [patent_app_country] => US [patent_app_date] => 2018-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 15971 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123860 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/123860
Pesticidal fusion protein improvements Sep 5, 2018 Issued
Array ( [id] => 18201217 [patent_doc_number] => 11583589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Cell membrane penetrating conjugates [patent_app_type] => utility [patent_app_number] => 16/640865 [patent_app_country] => US [patent_app_date] => 2018-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 30 [patent_no_of_words] => 21624 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640865 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/640865
Cell membrane penetrating conjugates Aug 21, 2018 Issued
Array ( [id] => 17952454 [patent_doc_number] => 11478528 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Antimicrobial peptides against [patent_app_type] => utility [patent_app_number] => 16/630615 [patent_app_country] => US [patent_app_date] => 2018-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 14925 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630615 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/630615
Antimicrobial peptides against Jul 15, 2018 Issued
Array ( [id] => 16799102 [patent_doc_number] => 10994018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-04 [patent_title] => Long-acting palmitic acid-conjugated GnRH derivative, and pharmaceutical composition containing same [patent_app_type] => utility [patent_app_number] => 16/630704 [patent_app_country] => US [patent_app_date] => 2018-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5395 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630704 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/630704
Long-acting palmitic acid-conjugated GnRH derivative, and pharmaceutical composition containing same Jun 19, 2018 Issued
Array ( [id] => 18664874 [patent_doc_number] => 11771739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Methods and compositions for treating microbial inflammation [patent_app_type] => utility [patent_app_number] => 16/622469 [patent_app_country] => US [patent_app_date] => 2018-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19377 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622469 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/622469
Methods and compositions for treating microbial inflammation Jun 17, 2018 Issued
Array ( [id] => 13604755 [patent_doc_number] => 20180353926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => Preparation of Templates for Nucleic Acid Sequencing [patent_app_type] => utility [patent_app_number] => 16/010902 [patent_app_country] => US [patent_app_date] => 2018-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18763 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010902 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/010902
Preparation of templates for nucleic acid sequencing Jun 17, 2018 Issued
Menu